BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 33862117)

  • 1. Identification of dysregulated competing endogenous RNA networks in glioblastoma: A way toward improved therapeutic opportunities.
    Rahnama S; Bakhshinejad B; Farzam F; Bitaraf A; Ghazimoradi MH; Babashah S
    Life Sci; 2021 Jul; 277():119488. PubMed ID: 33862117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of ncRNAs as ceRNAs in Gastric Cancer.
    Ye J; Li J; Zhao P
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A new look at hallmarks of breast cancer.
    Abdollahzadeh R; Daraei A; Mansoori Y; Sepahvand M; Amoli MM; Tavakkoly-Bazzaz J
    J Cell Physiol; 2019 Jul; 234(7):10080-10100. PubMed ID: 30537129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative Analysis of ceRNA Network Reveals Functional lncRNAs in Intrahepatic Cholangiocarcinoma.
    Zhou D; Gao B; Yang Q; Kong Y; Wang W
    Biomed Res Int; 2019; 2019():2601271. PubMed ID: 31886187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of the whole coding and non-coding RNA transcriptome expression profiles and construction of the circRNA-lncRNA co-regulated ceRNA network in laryngeal squamous cell carcinoma.
    Zhao R; Li FQ; Tian LL; Shang DS; Guo Y; Zhang JR; Liu M
    Funct Integr Genomics; 2019 Jan; 19(1):109-121. PubMed ID: 30128795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competitive endogenous RNA networks: Decoding the role of long non-coding RNAs and circular RNAs in colorectal cancer chemoresistance.
    Khalafizadeh A; Hashemizadegan SD; Shokri F; Bakhshinejad B; Jabbari K; Motavaf M; Babashah S
    J Cell Mol Med; 2024 Apr; 28(7):e18197. PubMed ID: 38506091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyzing the Interactions of mRNAs and ncRNAs to Predict Competing Endogenous RNA Networks in Osteosarcoma Chemo-Resistance.
    Zhu KP; Zhang CL; Ma XL; Hu JP; Cai T; Zhang L
    Mol Ther; 2019 Mar; 27(3):518-530. PubMed ID: 30692017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The non-coding competing endogenous RNAs in acute myeloid leukemia: biological and clinical implications.
    Zhou Q; Shu X; Chai Y; Liu W; Li Z; Xi Y
    Biomed Pharmacother; 2023 Jul; 163():114807. PubMed ID: 37150037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mathematical Modeling of ceRNA-Based Interactions.
    Dhawan A
    Methods Mol Biol; 2021; 2324():105-114. PubMed ID: 34165711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Novel Multi-Omics Expression Landscapes and Meta-Analysis of Landscape-Based Competitive Endogenous RNA Networks in ALDH+ Lung Adenocarcinoma Stem Cells.
    Yang W; Liang Y; Zheng Y; Luo H; Yang X; Li F
    Biomed Res Int; 2022; 2022():9545609. PubMed ID: 36093399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme.
    Zhang K; Li Q; Kang X; Wang Y; Wang S
    Oncol Rep; 2016 Nov; 36(5):2911-2925. PubMed ID: 27600337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncoding RNA:RNA Regulatory Networks in Cancer.
    Chan JJ; Tay Y
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29702599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA-associated ceRNA network involved in HIF-1 signalling in triple-negative breast cancer: circ_0047303 as a potential key regulator.
    Darbeheshti F; Mahdiannasser M; Noroozi Z; Firoozi Z; Mansoori B; Daraei A; Bastami M; Nariman-Saleh-Fam Z; Valipour E; Mansoori Y
    J Cell Mol Med; 2021 Dec; 25(24):11322-11332. PubMed ID: 34791795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of circRNA‑associated ceRNA networks in patients with nonvalvular persistent atrial fibrillation.
    Zhang Y; Ke X; Liu J; Ma X; Liu Y; Liang D; Wang L; Guo C; Luo Y
    Mol Med Rep; 2019 Jan; 19(1):638-650. PubMed ID: 30483740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma.
    Yuan Y; Jiaoming L; Xiang W; Yanhui L; Shu J; Maling G; Qing M
    J Neurooncol; 2018 May; 137(3):493-502. PubMed ID: 29335913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison and analysis of lncRNA-mediated ceRNA regulation in different molecular subtypes of glioblastoma.
    Li Q; Yu Q; Ji J; Wang P; Li D
    Mol Omics; 2019 Dec; 15(6):406-419. PubMed ID: 31584593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational Identification of Cross-Talking ceRNAs.
    Li Y; Huo C; Lin X; Xu J
    Adv Exp Med Biol; 2018; 1094():97-108. PubMed ID: 30191491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competing endogenous RNAs in lung cancer.
    Zhao M; Feng J; Tang L
    Cancer Biol Med; 2021 Feb; 18(1):1-20. PubMed ID: 33628581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).
    Xu Y; Chen J; Yang Z; Xu L
    Med Sci Monit; 2019 Feb; 25():1140-1154. PubMed ID: 30745559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parameter optimization for constructing competing endogenous RNA regulatory network in glioblastoma multiforme and other cancers.
    Chiu YC; Hsiao TH; Chen Y; Chuang EY
    BMC Genomics; 2015; 16 Suppl 4(Suppl 4):S1. PubMed ID: 25917195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.